Royal Philips has launched AffinitiCVx to offer better support to cardiology departments in providing enhanced care to more patients with increased efficiency and throughput.

This is the latest addition to the company’s dedicated cardiovascular ultrasound solutions and is developed to scale up productivity.

It provides cardiologists with a tailored workflow by integrating with a common platform that was first released with the Philips’ premium cardiology ultrasound system, EPIQ CVx.

Affiniti CVx consists of a common configurable UI, a number of popular automated tools and the transducers. Additionally, TEE transducers have been added across the Affiniti CVx and EPIQ CVx systems.

Furthermore, the new system features AutoStrain technology, which is said to slash strain analysis time by as much as 70%.

These features will enable cardiology departments to standardise their ultrasound fleet for better management, simplify cross-platform clinician training and minimise the total cost of ownership, the company added.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Cardiologist and at PhilipsCardiology and Personal Health medical officer Dr.Alexandra Gonçalves said: “The Covid-19 pandemic has created an urgent need for nimble, user-friendly cardiac ultrasound solutions that can keep patients and healthcare providers safe while also generating the data needed to make confident decisions.

“With Release 7.0 of EPIQ CVx and AffinitiCVx, we’ve sharpened our focus on improving the cardiology experience by increasing the integration of our platforms to meet this demand.Taken together, these releases help cardiology teams work faster and with greater precision and efficiency so that they can deliver the best possible heart care.”

Philips is launching its new AffinitiCVx at At ESC 2020. The company is also releasing its 7.0 for EPIQ CVx cardiovascular ultrasound solutions, with upgrades to advance confidence in diagnosis and procedures, and offer enhanced the user experience.